US 12030897
Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof
granted A61PA61P15/14A61P35/00
Quick answer
US patent 12030897 (Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof) held by Medshine Discovery Inc. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P15/14, A61P35/00